Abstract:Tau, an intrinsically disordered neuronal protein and polyampholyte with an overall positive charge, is a microtubule (MT) associated protein, which binds to anionic domains of MTs and suppresses their dynamic instability. Aberrant tau-MT interactions are implicated in Alzheimer's and other neurodegenerative diseases. Here, we studied the interactions between full length human protein tau and other negatively charged binding substrates, as revealed by differential- interference-contrast (DIC) and fluorescence microscopy. As a binding substrate, we chose anionic liposomes (ALs) containing either 1,2-dioleoyl-sn-glycero-3-phosphatidylserine (DOPS, -1e) or 1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol (DOPG, -1e) mixed with zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) to mimic anionic plasma membranes of axons where tau resides. At low salt concentrations (0 to 10 mM KCl or NaCl) with minimal charge screening, reaction mixtures of tau and ALs resulted in the formation of distinct states of AL-tau complexes coexisting with liquid-liquid phase separated tau self-coacervates arising from the polyampholytic nature of tau containing cationic and anionic domains. AL-tau complexes exhibited distinct types of morphologies. This included, large ≈20-30 micron tau-decorated giant vesicles with additional smaller liposomes with bound tau attached to the giant vesicles, and tau- mediated finite-size assemblies of small liposomes. As the ionic strength of the solution was increased to near and above physiological salt concentrations for 1:1 electrolytes (≈150 mM), AL-tau complexes remained stable while tau self-coacervate droplets were found to dissolve indicative of breaking of (anionic/cationic) electrostatic bonds between tau chains due to increased charge screening. The findings are consistent with the hypothesis that distinct cationic domains of tau may interact with anionic lipid domains of the lumen facing monolayer of the axon plasma membrane suggesting the possibility of transient yet robust interactions at physiologically relevant ionic strengths.

Biphasic modulation of tau liquid-liquid phase separation by polyphenols

Tannic acid as a biphasic modulator of tau protein liquid-liquid phase separation

Cyclic dipeptide-based small molecules modulate zinc-mediated liquid-liquid phase separation of tau

Liquid − liquid phase separation of tau: Driving forces, regulation, and biological implications

Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease

Tau liquid–liquid phase separation: At the crossroads of tau physiology and tauopathy

Liquid-liquid phase separation of tau driven by hydrophobic interaction facilitates fibrillization of tau

Polycatechols inhibit ferroptosis and modulate tau liquid–liquid phase separation to mitigate Alzheimer's disease

Liquid-liquid phase separation induces pathogenic tau conformations in vitro

Liquid–liquid phase separation in Alzheimer's disease

Tau protein liquid–liquid phase separation can initiate tau aggregation

Light Microscopy and Dynamic Light Scattering to Study Liquid-Liquid Phase Separation of Tau Proteins In Vitro

Liquid-Liquid Phase Separation of Tau Protein is Encoded at the Monomeric Level

Methylene blue accelerates liquid-to-gel transition of tau condensates impacting tau function and pathology

Conformational Expansion of Tau in Condensates Promotes Irreversible Aggregation.

Modulating disease-relevant tau oligomeric strains by small molecules

Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase Separated Coacervates

Molecular Hairpin: a Possible Model for Inhibition of Tau Aggregation by Tannic Acid.

New Strategy for Reducing Tau Aggregation Cytologically by A Hairpinlike Molecular Inhibitor, Tannic Acid Encapsulated in Liposome

Liquid-Liquid Phase Separation (LLPS)-Driven Fibrilization of Amyloid-β Protein

Initiation and modulation of Tau protein phase separation by the drug suramin